La cadena de opciones muestra datos clave de las opciones de acciones de Moleculin Biotech a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Moleculin Biotech..

Moleculin Biotech (NASDAQ:MBRX) Bolsa, Cadena de Opciones

Moleculin Biotech

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

ABNB

BLAC

BSLK

CNSP

FFIE

INFA

JRSH

MBRX

MYNA

PCLA

SLSR

STAI

STVN

VRPX

ZCAR

Airbnb supera expectativas de ingresos y sus acciones suben un 13,9% en premercado. Descubre qué otros valores están destacando hoy.

Acciones de Airbnb (ABNB) suben alrededor del 14%; 20 acciones que se mueven en el premercado de EE.UU.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

APPS

AVGR

BBAI

COHR

DGLY

FORM

MTRX

PTIX

RANI

RXRX

SBET

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SLXN

SWKS

Coherent sorprende con sus resultados trimestrales y dispara sus acciones un 15,5%. ¿Qué otras empresas se mueven en el premercado de EE.UU.?

Acciones de Coherent (COHR) se disparan un 15%; 20 acciones que se mueven en el premercado de EE.UU.

Moleculin Biotech Inc

Seaport Global analyst Michael Harrison upgrades Innospec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOSP#NASDAQ">IOSP</a>) from Neutral to Buy and announces $155 price target.

Upgrades

Price Target

Analyst Ratings

IOSP

Seaport Global Upgrades Innospec to Buy, Announces $155 Price Target

WIIM

Capital One and Discover shares are trading higher after the Board of Governors of the Federal Reserve System and the Office of the Comptroller of the Currency approved their proposed merger.

TSLA: -4% &#x7C; <a href="https://www.benzinga.com//node/44893694">Tesla shares are trading lower following a report indicating the company postponed the US debut of an affordable version of its Model Y SUV.</a>
&nbsp;
NFLX: 5% &#x7C; <a href="https://www.benzinga.com//node/44893675">Netflix shares are trading higher after the company on Thursday reported a Q1 earnings beat and issued strong Q2 guidance.</a>
&nbsp;
IVVD: 22% &#x7C; <a href="https://www.benzinga.com//node/44893948">Invivyd shares are trading higher after the company signed a $30 million term loan facility with Silicon Valley Bank.</a>

IVVD

NFLX

TSLA

Market-Moving News for April 21st

A growing number of cryptocurrency companies are preparing to enter the U.S. banking system, propelled by a policy shift under President Donald Trump aimed at <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42644568/institutional-crypto-adoption-for-real-this-time-says-messari">integrating digital assets into mainstream finance</a>.
What Happened: Firms like Circle (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) and BitGo are planning to apply for bank charters, The Wall Street Journal <a href="https://www.wsj.com/finance/currencies/crypto-knocks-on-the-door-of-a-banking-world-that-shut-it-out-082b3968">reported</a>, quoting sources.
Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) and Paxos are also exploring regulatory approvals to operate with similar authority. 
These developments follow the Trump administration's commitment to establishing the U.S. as a global leader in digital assets, including through new legislation targeting stablecoin oversight.
Recent bills moving through Congress propose a <a href="https://www.benzinga.com/content/44516699/u-s-congress-advances-stablecoin-regulation-with-the-introduction-of-the-stable-act">regulatory framework for stablecoins</a>, mandating that issuers secure banking licenses or charters.
These digital tokens, typically pegged to fiat currencies, are used as a bridge between volatile cryptocurrencies and traditional money.
Some crypto firms are aiming for national trust bank or industrial bank charters that are essentially licenses that would allow them to hold customer deposits or issue loans. 
Others are seeking limited permissions specifically for issuing stablecoins.
BitGo, a crypto custody firm and reserve manager for the Trump family's stablecoin project USD1, is nearing the submission of its bank charter application, according to individuals familiar with its plans.
Anchorage Digital, currently the only federally chartered crypto bank in the U.S., has invested tens of millions of dollars to meet regulatory standards. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44867243/binance-advising-nations-on-strategic-bitcoin-reserves-crypto-regulation-report">Binance Advising Nations On Strategic Bitcoin Reserves, Crypto Regulation: Report</a>
CEO Nathan McCauley acknowledged the operational challenges, saying, "It has not been easy," but emphasized the importance of intertwining full regulatory compliance with the crypto sector.
Anchorage recently became a custodian for BlackRock's iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) and partnered with Cantor Fitzgerald and Copper on a $2 billion bitcoin-backed lending initiative. 
Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>), the world's largest stablecoin by market cap at $145 billion, is a major Cantor client.
This integration marks a reversal from two years ago when the collapses of crypto firms and banks like Silvergate and Signature led to a regulatory clampdown, forcing traditional financial institutions to distance themselves from the crypto sector.
Why It Matters: Trump's return to office has changed the tone.
Regulations that once required banks to seek explicit approval before offering crypto services have been softened, and new federal guidance on bank-crypto relationships is expected later this year.
Legacy financial institutions are adjusting course. 
Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) CEO Brian Moynihan said in February the bank is prepared to issue a stablecoin once legal clarity is established. 
U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) has also resumed crypto custody services via a partnership with NYDIG.
International banks are taking note. 
A consortium including Deutsche Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) and Standard Chartered (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SCBFF#OTC">SCBFF</a>) is exploring expansion into the U.S. crypto market. Deutsche Bank declined to comment, and Standard Chartered did not respond.
However, caution persists in some corners. 
KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) CEO Chris Gorman noted potential competitive threats from crypto and cited regulatory concerns, particularly around transparency and anti-money laundering enforcement. "It's hard to trace," he said.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44861571/donald-trump-blasts-too-late-and-wrong-fed-chair-powell-but-polymarket-traders-doubt-his-termination-will-come-fast-enough">Donald Trump Blasts &#8216;Too Late And Wrong&#8217; Fed Chair Powell, But Polymarket Traders Doubt His &#8216;Termination&#8217; Will Come &#8216;Fast Enough&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$USDC

$USDT

COIN

IBIT

SCBFF

Deutsche Bank, Standard Chartered Reportedly Looking Into Expanding To US Crypto Market

Needham analyst Chris Pierce reiterates Archer Aviation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) with a Buy and maintains $13 price target.

Reiteration

ACHR

Needham Reiterates Buy on Archer Aviation, Maintains $13 Price Target

Piper Sandler analyst Andrew Liesch maintains Westamerica Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WABC#NASDAQ">WABC</a>) with a Neutral and lowers the price target from $54 to $50.

WABC

Piper Sandler Maintains Neutral on Westamerica Bancorp, Lowers Price Target to $50

Barrington Research analyst Gary Prestopino maintains LKQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) with a Outperform and maintains $60 price target.

Barrington Research Maintains Outperform on LKQ, Maintains $60 Price Target

Barrington Research analyst Michael Petusky maintains Option Care Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPCH#NASDAQ">OPCH</a>) with a Outperform and maintains $38 price target.

OPCH

Barrington Research Maintains Outperform on Option Care Health, Maintains $38 Price Target

HemoSphere Alta&#x2122; Advanced Monitoring Platform with Predictive, Smart Algorithms Helps Clinicians Proactively Address Instability in Blood Flow and Pressure in Critical Situations
FRANKLIN LAKES, N.J., April 21, 2025 /PRNewswire/ --&nbsp;BD (Becton, Dickinson and Company) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDX#NYSE">BDX</a>), a leading global medical technology company, has launched a new advanced hemodynamic monitoring platform with predictive, artificial intelligence (AI) based algorithms that can help clinicians proactively address blood pressure instability and optimize blood flow to help avoid potential life-threatening situations during procedures.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
HemoSphere Alta&#x2122; platform is the company's most advanced hemodynamic monitoring technology available and is the first major product launch from the Advanced Patient Monitoring business since its acquisition by BD. The new product advances BD's leadership in smart, connected care technologies that use clinical data and AI to help clinicians improve patient outcomes and optimize clinical workflows.
 &nbsp;

BD Unveils HemoSphere Alta Advanced Monitoring Platform With Predictive, AI Based Algorithms

On April&nbsp;17, 2025, the U.S. Department of the Army announced through the publication of its Justification to Fair Opportunity ("JEFO") on SAM.gov that it will extend the current period of performance for the various task orders under the&nbsp;Logistics Civil Augmentation Program V indefinite delivery and indefinite quantity contract to support U.S. military operations worldwide ("LOGCAP V") with V2X,&nbsp;Inc. The Company is one of four award recipients of LOGCAP V and has several task orders, including the Kuwait Task Order,&nbsp;Iraq Task Order and INDOPACOM Task Order, among others, each of which is scheduled to extend through June&nbsp;2030.

Government

Regulations

V2X Inc. Secures Extended Military Support Contracts Under US Army's LOGCAP V Program

<a href="https://www.reuters.com/world/china/huawei-readies-new-ai-chip-mass-shipment-china-seeks-nvidia-alternatives-sources-2025-04-21/" title="https://www.reuters.com/world/china/huawei-readies-new-ai-chip-mass-shipment-china-seeks-nvidia-alternatives-sources-2025-04-21/">https://www.reuters.com/world/china/huawei-readies-new-ai-chip-mass-shipment-china-seeks-nvidia-alternatives-sources-2025-04-21/</a>

Tech

NVDA

Reuters Reported Earlier Huawei Preparing New AI Chip For Mass Shipment As Nvidia Alternative

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/18040107/Chagee-news-wrap-0418-900x600-1.png" alt="" class="wp-image-11026" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/18040107/Chagee-news-wrap-0418-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/18040107/Chagee-news-wrap-0418-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/18040107/Chagee-news-wrap-0418-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The listing was the first in the U.S. by a Chinese premium tea drink maker, which prides itself on the simplicity of its products and focus on the country's ancient tea culture
Premium tea drink maker&nbsp;Chagee Holdings Ltd.&nbsp;(CHA.US)&nbsp;<a href="https://www.globenewswire.com/news-release/2025/04/17/3063193/0/en/Chagee-Holdings-Limited-Announces-Pricing-of-Initial-Public-Offering.html">raised</a>&nbsp;$411 million (3 billion yuan) this week in the biggest IPO this year by a Chinese company, setting itself apart from a crowded group not only by being first to list in the U.S., but also with its traditional approach to one of China's most famous drinks.
The company raised the sum by selling 14.7 million American depositary shares (ADS) to investors for $28 each and could raise an additional $61.6 million if its underwriters exercise an overallotment option. That makes it the biggest U.S. IPO by a Chinese company since robotaxi operator Pony AI raised about $400 million in a Nasdaq IPO last November. Chagee's stock rose 15.9% on Thursday, its first trading day, valuing the company at $5.95 billion.
Founded in 2017 in Southwest China's Yunnan province, famous for its pu'er-style teas, Chagee has set itself apart from its peers with its simpler, more purist approach to China's tea culture that dates back thousands of years. The company likes to say that such culture is "in its bones," with most of its drinks consisting of milk and tea in various combinations.
That differs markedly from its rivals, many of those listed in Hong Kong, that add a wide range of ingredients to their products, from tapioca pearls, to cheese foam and fruit. The company also emphasizes traditional themes in its packaging and store decorations, including a logo inspired from Consort Yu, a famous figure in Peking Opera.
Chagee is also famous for its homier, more comfortable stores, with some likening that to the approach used by global coffee giant Starbucks. Unlike most of its rivals, whose shops often consist of little more than a window where customers can grab their order and go, Chagee's shops contain seating areas where people can consume their drinks, reminiscent of Starbucks' "third place" concept.
Also like Starbucks, the company prides itself on its treatment of employees, and invited some of those everyday workers, along with some of its franchisees, to ring the opening bell when its shares started trading on the Nasdaq.
Chagee is very much like its peers in reporting explosive growth over the last few years, riding a wave of popularity for their high-end tea drinks among China's growing urban class. Its store count jumped about sixfold from 1,087 shops in the fourth quarter of 2022 to 6,440 at the end of 2024, with franchisees accounting for 97% of those. The company's revenue has grown at a similar rate, rising to 12.4 billion yuan ($1.7 billion) last year from 492 million yuan in 2022.
The company recorded its first profit of 803 million yuan in 2023, and the figure more than tripled last year to 2.51 billion yuan.
In addition to its core China operation, Chagee also sees global expansion as a major new frontier going forward. The company disclosed in its prospectus that it is aiming to operate 1,000 to 1,500 global stores by the end of this year, and has also separately confirmed it plans to open its first U.S. store in Los Angeles later this year.

Asia

Equities

IPOs

Nasdaq IPO Positions Chagee For Global Expansion

Wells Fargo initiates coverage on Staar Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAA#NASDAQ">STAA</a>) with a Equal-Weight rating and announces Price Target of $17.

Initiation

STAA

Wells Fargo Initiates Coverage On Staar Surgical with Equal-Weight Rating, Announces Price Target of $17

Piper Sandler analyst Matt Farrell maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Overweight and raises the price target from $1100 to $1150.

Piper Sandler Maintains Overweight on Netflix, Raises Price Target to $1150

Money‑management guru Dave&nbsp;Ramsey is urging Americans to treat Social Security as a bonus, not a backbone, warning that the program's cash crunch could slice benefits within a decade.
What Happened: "Don't count on it. Or don't count on all of it," a Ramsey Solutions blog <a href="https://www.ramseysolutions.com/retirement/how-does-social-security-work#cookie-banner">post</a> says, bluntly rebranding the program as "Social Insecurity.
The alarm reflects the latest Social Security Trustees <a href="https://www.ssa.gov/oact/trsum/">report</a>, which projects the combined retirement and disability trust funds will run dry in 2035; ongoing payroll taxes would then cover only about 83 percent of promised checks. Demographic math compounds the squeeze: 2.7 workers now support each beneficiary, a ratio expected to fall to 2.4 by 2035 as baby boomers swell the over‑65 population from 61 million to 77 million.
Fear of a haircut is widespread. An AARP <a href="https://www.aarp.org/social-security/benefits-current-status-future-stability/">survey</a> found 75 percent of Americans 50 and older doubt the system will be there when they need it.
See also: <a href="https://www.benzinga.com/25/04/44829975/joe-biden-calls-social-security-a-sacred-promise-slams-trump-administrations-efforts-to-damage-the-program-theyre-shooting-first-and-aiming-later">Joe Biden Calls Social Security A &#8216;Sacred Promise,&#8217; Slams Trump Administration&#8217;s Efforts To Damage The Program: &#8216;They&#8217;re Shooting First And Aiming Later&#8217;</a>
Lawmakers have floated fixes ranging from higher payroll caps to later retirement ages, but Congress has failed to pass a solvency package since 1983. Ramsey's advice: assume reform stalls and build a private nest egg. "If by some miracle Social Security is around when you retire, you'll have some extra money to work with," he writes. "But understand, it's your job to take care of you and your family, not Uncle Sam's."
With trust‑fund depletion inching closer each spring, the personal‑finance host's blunt mantra lands as a rallying cry: plan for less, save for more, and treat any future check as gravy.
What To Know: Ramsey has previously warned that Social Security was never meant to fund a full retirement. The average 2025 benefit of&nbsp;$1,976 a month leaves most retirees short, so he <a href="https://www.benzinga.com/personal-finance/25/01/43064384/dave-ramseys-top-warnings-about-social-securitys-flaws-and-how-to-protect-your-financial-future">urges people</a> to become debt‑free, stock an emergency fund, and invest 15% of their income for the future.
He also flags the program's <a href="https://www.benzinga.com/24/12/42273289/suze-orman-slams-social-security-fearmongering-you-really-think-washington-is-going-to-do-nothing-and-cut-benefits-by-25-cmon">shaky outlook</a>: its trust funds could run dry by&nbsp;2035, cutting payments by roughly a quarter as the worker‑to‑beneficiary ratio shrinks. Ramsey tells clients to view Social Security as a bonus, <a href="https://www.benzinga.com/personal-finance/24/08/40374894/financial-guru-dave-ramsey-advises-take-social-security-at-62-but-this-essential-step-is-non-neg">claim at&nbsp;62</a> only if they invest the checks, and build wealth through disciplined saving rather than rely on Washington.
Read next: <a href="https://www.benzinga.com/personal-finance/25/04/44890948/she-collected-her-moms-social-security-for-25-years-now-shes-facing-justice">She Collected Her Mom&#8217;s Social Security For 25 Years — Now She&#8217;s Facing Justice</a>

Education

General

Dave Ramsey Tells Retirees 'Don't Count On it, Or Don't Count On All Of It' — Why He Doubts Social Security's Future

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that Marwan Noel Sabbagh, MD, Professor of Neurology at Barrow Neurological Institute and Chairman of Anavex's Scientific Advisory Board gave an oral presentation titled, "Oral Blarcamesine Novel Mechanism for Alzheimer Disease: Autophagy Restoration through Upstream SIGMAR1 Activation Clinical Efficacy Phase IIb/III Trial" at the 9th International Conference on Alzheimer's Disease and Related Disorders in the Middle East.
The ‘9th International Conference on Alzheimer's Disease and Related Disorders in the Middle East' was held April 18-20, 2025 in Abu Dhabi, United Arab Emirates (UAE). The meeting convened clinicians including neurologists, psychiatrists, and geriatricians, nurses, public health workers, researchers, social workers, students, caregivers, and community advocates from the Middle East and North Africa (termed the MENA region), USA, Europe and other countries with an interest in epidemiology, clinical/research, medicine, basic science, and healthcare advocacy related to Alzheimer's disease and related disorders (ADRD) in the region. Specifically, an emphasis on region specific healthcare delivery were addressed.

AVXL

Anavex Says Marwan Noel Sabbagh Presents Blarcamesine Phase IIb/III Findings At 9th International Conference On Alzheimer's Disease and Related Disorders in Middle East

Chinese battery manufacturer CATL (Contemporary Amperex Technology Co. Limited) has launched the second-generation ‘Shenxing' fast-charging battery.
What Happened: The company announced the second-generation battery at an event in Shanghai, reported Reuters on Monday. Shenxing batteries would power over 67 new EVs this year, CATL's Chief Technology Officer, Gao Huan, said.
The new battery would enable a range of 520 km or approximately 323 miles on a 5-minute charge. The battery can also be charged from 0% to 80% in 15 minutes in cold weather.
The report also shares that, besides the new battery, CATL also unveiled a new brand called Naxtra for the company's Sodium-ion batteries. Sodium-ion batteries could help reduce the risk of a fire in EVs, some experts suggest.
Why It Matters: Last year, CATL, whose customers also include the likes of Volkswagen AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VLKAF#OTC">VLKAF</a>) and Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), was seeking over <a href="https://www.benzinga.com/news/24/07/39745306/tesla-supplier-catl-seeks-1-5b-funding-to-expand-global-ev-battery-supply-chain">$1.5 billion in funding</a> to bolster its EV battery supply chain.&nbsp;
Elsewhere, fast-charging tech throughout the globe is experiencing rapid development. Recently, leading Chinese automaker BYD Co., Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDF#OTC">BYDDF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDD#OTC">BYDD</a>) <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44630091/teslas-ev-crown-at-risk-as-byd-closes-in-with-breakthrough-charging-tech">unveiled its fast-charging technology</a>, which could provide approximately 250 miles of range through a 5-minute charge.
In contrast, Tesla Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44245123/teslas-charging-empire-faces-headwinds-as-ev-market-stumbles">superchargers provide 170 miles</a> of range on a 10-minute charge, significantly lower than BYD's tech.
Check out more of Benzinga's Future Of Mobility coverage by <a href="https://www.benzinga.com/topic/mobility">following this link</a>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/tech/25/04/44892799/teslas-india-play-deepens-as-elon-musks-ev-giant-explores-alternate-semiconductor-supply-chains-amid-us-china-trade-war">Tesla&#8217;s India Play Deepens As Elon Musk&#8217;s EV Giant Explores Alternate Semiconductor Supply Chains Amid US-China Trade War</a></li>
</ul>
Image Via Shutterstock

BYDD

BYDDF

VLKAF

Tesla Battery Supplier CATL Unveils New Fast-Charging Battery With 323-Mile Range In Five Minutes

The U.S. is accelerating the permitting process for 10 critical mineral production projects under the FAST-41 program following President Donald Trump's <a target="_blank" href="https://www.benzinga.com/government/regulations/25/03/44471105/trumps-executive-order-fuels-investor-speculation-over-alaskan-resources" rel="noreferrer noopener">executive order</a> to reduce the country's reliance on foreign mineral imports.
The initiative seeks to remove bureaucratic hurdles, secure essential minerals, and strengthen domestic supply chains.
"This is the first use of the Permitting Council's transparency authority, and we look forward to showcasing the many benefits the Federal Permitting Dashboard can bring to critical infrastructure projects," <a target="_blank" href="https://www.whitehouse.gov/articles/2025/04/trump-administration-advances-first-wave-of-critical-mineral-production-projects/" rel="noreferrer noopener">said</a> Manisha Patel, Acting Executive Director at the Permitting Council. "It's a vital tool for interagency coordination and efficient decision-making," he added.
The newly designated projects include major proposals across the country such as Perpetua Resources' (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPTA#NASDAQ">PPTA</a>) Stibnite Gold and Antimony Project in Idaho, Rio Tinto's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) Resolution Copper Project in Arizona, Hecla Mining's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) copper and silver mine in Montana, and Albemarle's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) expansion of the Silver Peak lithium mine in Nevada. Also included are Standard Lithium's direct lithium extraction site in Arkansas, Warrior Met Coal's metallurgical coal mine in Alabama, and the McDermitt Lithium Project in Oregon. Others include the Caldwell Canyon Phosphate Mine in Idaho, Lisbon Valley Copper in Utah, and Michigan Potash.
These projects are now subject to the FAST-41 framework, which provides enhanced interagency coordination and a centralized online dashboard for monitoring permitting progress. While the program doesn't waive environmental laws, it significantly improves process transparency and helps enforce clearer timelines.
The U.S. depends heavily on foreign sources, particularly China, for critical minerals such as lithium, copper, and rare earth elements, crucial for electric vehicles, military equipment, and consumer electronics. Lengthy permitting processes, which can take anywhere from <a target="_blank" href="https://www.benzinga.com/news/24/07/39870803/us-mine-development-delays-among-worlds-longest-second-only-to-zambia" rel="noreferrer noopener">10 to 29 years</a>, have hindered domestic production, forcing reliance on geopolitical competitors. By comparison, countries like Canada and Australia approve mines in two to five years, giving them a significant advantage in attracting investment and securing supply chains.
Even in Canada, where permitting is relatively faster, both leading candidates for prime minister—Mark Carney and Pierre Poilievre—have campaigned on promises to <a target="_blank" href="https://www.benzinga.com/25/04/44732611/canadian-politicians-promise-faster-project-approvals-ahead-of-april-28-elections" rel="noreferrer noopener">reduce mining bureaucracy</a> further.
"For too long, duplicative processes and regulatory paralysis have delayed the development of the minerals America needs," <a target="_blank" href="https://www.doi.gov/pressreleases/trump-administration-adds-key-mining-projects-fast-41" rel="noreferrer noopener">said</a> Adam Suess, Acting Assistant Secretary for Land and Minerals Management. "By cutting red tape and increasing accountability, we're making it clear that under President Trump, the United States is serious about being a global leader in critical minerals."
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44891559/chinas-gold-stash-soars-to-2292-tonnesand-its-still-buying" target="_blank" rel="noreferrer noopener">China's Central Bank's Gold Stash Spikes To 2,292 Tonnes And Beijing Is Still Buying</a></li>
</ul>
Photo by Juan Roballo via Shutterstock

Large Cap

Commodities

Politics

Legal

PPTA

Trump Administration Fast-Tracks Ten Domestic Critical Mineral Projects

William Blair analyst Stephen Sheldon initiates coverage on Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) with a Market Perform rating.

William Blair Initiates Coverage On Zillow Gr with Market Perform Rating

Nano Dimension Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNDM#NASDAQ">NNDM</a>) ("Nano Dimension" or the "Company"), a leader in Digital Manufacturing solutions, today provided an update on Desktop Metal.
Desktop Metal, a subsidiary of Nano Dimension, has commenced a process to explore all available strategic alternatives to address its liabilities and liquidity needs. Desktop Metal has appointed Robert Warshauer to its Board of Directors and engaged Piper Sandler &amp; Co. and FTI Consulting, Inc. as financial advisers.
No assurances can be given as to the outcome or timing of the strategic review process. Nano Dimension plans to share additional details during its upcoming 2024 financial results and 2025 outlook call, expected to be held in late April 2025.

NNDM

Nano Dimension Announces Strategic Review for Desktop Metal to Address Liabilities and Liquidity Needs

Press Releases

"Signal Advance, Inc. (OTC: SIGL) Achieves Technology Milestone with Revolutionary Next-Gen Signal Protection – More Stocks Inside"

Small Cap

Moleculin Abstract Accepted for Poster Presentation at the Acute Leukemias XIX (ISALXIX) International Symposium

Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity

Moleculin to Present at the 37th Annual ROTH Conference

Moleculin Biotech, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference

Virtual Investor Releases Next Wave of "Top 5 for '25" On-Demand Videos

Moleculin to Report Full Year 2024 Financial Results on March 21, 2025 and Host Conference Call and Webcast

Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update

Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial

Moleculin Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025

Comments

Moleculin Biotech

Moleculin Biotech (MBRX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL